American Run For the End-Aids is categorized under Aids Information and Testing in New York City, NY .
American Run For the End-Aids was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Aids Information and Testing business, which does work in the B2C market, and is classified as a Aids Information and Testing, under code number 6219990 by the NAICS.
If you are seeking more information, feel free to contact Brent Nickol-Earl, President at the company’s single location by writing to 2350 Broadway, New York City, New York NY 10024 or by phoning (212) 580-7668. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | American Run For the End-Aids |
Contact Person: | Brent Nickol-Earl, President |
Address: | 2350 Broadway, New York City, New York 10024 |
Phone Number: | (212) 580-7668 |
Annual Revenue (USD): | $100.000 to $499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Aids Information and Testing |
SIC Code: | 8099 |
NAICS Code: | 6219990 |
Share This Business: |
American Run For the End-Aids was started in 0 to provide professional Aids Information and Testing under the SIC code 8099 and NAICS code 6219990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Brent Nickol-Earl, President for inquiries that concern American Run For the End-Aids by calling the company number (212) 580-7668, as your correspondence is most welcome. Additionally, the physical location of the single location of American Run For the End-Aids can be found at the coordinates 40.788062,-73.976633 as well as the street address 2350 Broadway in New York City, New York 10024.
For its online presence, you may visit American Run For the End-Aids’s website at and engage with its social media outlets through on Twitter and on Facebook.